Ultrasound-guided pressure measurement for liver cirrhosis treatment
Part of Digestive system clinical trials.
This trial tests whether using an endoscopic ultrasound to measure pressure in your liver's blood vessels can help guide treatment for cirrhosis. The goal is to see if this measurement improves how well medications work to prevent serious bleeding in your stomach or esophagus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have advanced liver disease (cirrhosis).
- Your doctor must have said you need a medicine called a non-selective beta-blocker to help prevent bleeding.
- You must be at least 18 years old.
- You cannot be pregnant.
- You cannot have advanced liver cancer that can't be treated with a cure.
- You cannot have fluid buildup in your belly (ascites), a narrowing of your esophagus, or certain blood test results that are too high or too low.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a technique to measure blood pressure changes in people with cirrhosis (scarring of the liver). It may help doctors better understand liver circulation problems and guide safer treatment decisions.
This trial uses a minimally invasive ultrasound technique to directly measure blood pressure in the liver's main vein. It may help doctors decide if patients with severe scarred livers need medication to prevent variceal bleeding.
This trial compares a newer, less invasive method (using an endoscope) to measure pressure in the liver's blood vessels with the standard technique. It may help people with liver disease or suspected cirrhosis better understand their condition.
This study tests a new way to measure if a type of blood pressure medicine called non-selective beta-blockers (NSBBs) is helping patients with cirrhosis. It uses a thin, flexible tube with a camera (endoscope) to measure pressures in the liver and a nearby vein. If you have cirrhosis with high pressure in the portal vein but haven't started NSBBs yet, this study may help your doctor decide if the medicine is working for you.
This study measures the pressure in the blood vessels of the liver using an endoscopic ultrasound, a less invasive method, to see if it can replace the traditional pressure test. It aims to help doctors monitor liver cirrhosis and related complications more comfortably.
This study checks whether a special ultrasound-guided measurement of blood pressure in your liver can help predict how well endoscopic treatment (banding varices or injecting bleeding sites) will work. It aims to improve outcomes by identifying who is more likely to respond.
Hear when a new Portal Pressure Gradient (PPG) Measurement Guided by Endoscopic Ultrasound (EUS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.